0001415889-25-016991.txt : 20250612 0001415889-25-016991.hdr.sgml : 20250612 20250612170000 ACCESSION NUMBER: 0001415889-25-016991 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250610 FILED AS OF DATE: 20250612 DATE AS OF CHANGE: 20250612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boylan James P CENTRAL INDEX KEY: 0001953094 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39580 FILM NUMBER: 251043700 MAIL ADDRESS: STREET 1: C/O ENAVATE SCIENCES STREET 2: 2884 SAND HILL RD., STE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immunome Inc. CENTRAL INDEX KEY: 0001472012 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 770694340 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18702 N. CREEK PARKWAY STREET 2: SUITE 100 CITY: BOTHELL STATE: WA ZIP: 98011 BUSINESS PHONE: 610-321-3700 MAIL ADDRESS: STREET 1: 18702 N. CREEK PARKWAY STREET 2: SUITE 100 CITY: BOTHELL STATE: WA ZIP: 98011 4 1 form4-06122025_080657.xml X0508 4 2025-06-10 0001472012 Immunome Inc. IMNM 0001953094 Boylan James P C/O IMMUNOME, INC. 18702 N. CREEK PARKWAY, SUITE 100 BOTHELL WA 98011 true false false false 0 Director Stock Option (right to buy) 9.57 2025-06-10 4 A 0 18864 0 A 2035-06-09 Common Stock 18864 18864 D Mr. Boylan has agreed to receive and hold for the benefit of Enavate Sciences, LP, any securities granted to him for his service as a director on the Company's board of directors. As such, Mr. Boylan disclaims beneficial ownership of, and all right, title and interest in, the reported securities. The option vests in four quarterly installments, commencing from June 10, 2025 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to Mr. Boylan's continuous service with the Company on each respective vesting date. /s/ Sandra Stoneman, Attorney-in-Fact 2025-06-12